Valuation: Nanjing Well Pharmaceutical Group Co.,Ltd.

Market Cap 3.52B 528M 474M 438M 397M 742M 50.18B 751M 5.25B 2.08B 26.3B 1.98B 1.94B 83.4B P/E 2024
22.7x
P/E 2025 23.4x
Enterprise Value 3.67B 551M 494M 457M 414M 774M 52.32B 783M 5.47B 2.17B 27.43B 2.07B 2.02B 86.97B EV / Sales 2024
2.75x
EV / Sales 2025 2.75x
Free-Float
38.51%
Yield 2024
1.63%
Yield 2025 2.31%
10-01 Nanjing Well Pharmaceutical Group Co.,Ltd. authorizes a Buyback Plan. CI
10-01 Nanjing Well Pharmaceutical Group Co.,Ltd. announces an Equity Buyback for CNY 100 million worth of its shares. CI
08-21 Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 CI
06-16 Nanjing Well Pharmaceutical Group Co.,Ltd. signed a property rights transaction contract to acquire 50.98% stake in Lianyungang Wantai Pharmaceutical Excipients Technology Co., Ltd. from Tianjin Boguang Medical Biotechnology Development Co., Ltd. for CNY 19.4 million. CI
06-10 Nanjing Well Pharmaceutical Completes Updating Business Scope Registration MT
04-27 Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
04-27 Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
04-27 Nanjing Well Pharmaceutical Group Co.,Ltd. announces Annual dividend, payable on June 05, 2026 CI
29/10/25 Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
19/08/25 Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025 CI
22/04/25 Nanjing Well Pharmaceutical Group Co.,Ltd. announces Annual dividend, payable on June 13, 2025 CI
21/04/25 Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
21/04/25 Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024 CI
1 day-3.09%
1 week-3.13%
Current month-5.28%
1 month-4.23%
3 months+8.28%
6 months-0.46%
Current year-0.04%
1 week 25.03
Extreme 25.03
27.97
1 month 25.03
Extreme 25.03
29.54
Current year 21.9
Extreme 21.9
29.54
1 year 21.9
Extreme 21.9
30.8
3 years 17.65
Extreme 17.65
33.34
5 years 17.65
Extreme 17.65
42.62
10 years 17.08
Extreme 17.08
42.62
Manager TitleAgeSince
Chief Executive Officer 63 25/03/2017
Director of Finance/CFO 59 25/03/2017
Chief Tech/Sci/R&D Officer 61 25/03/2017
Director TitleAgeSince
Chairman 63 25/03/2017
Director/Board Member 61 25/03/2017
Director/Board Member 58 25/03/2017
Date Insider Type Main position Quantity % Market Cap. Importance
6/4/20 A Sell

Chairman

78,000 0.1307%
Change 5-day change 1-year change 3-year change Capi.($)
-3.09%-3.13%-4.90%-1.03% 528M
-2.51%+1.15%+55.18%+70.45% 740B
-1.71%-2.76%-20.94%+1.67% 170B
-7.36%-8.22%+122.18%+198.62% 122B
-2.87%+1.14%+40.53%+15.49% 126B
-9.24%-10.63%+122.16%+213.48% 112B
-7.03%-7.73%+98.29%+142.07% 107B
-1.09%+1.22%+8.06%+12.87% 94.11B
-3.98%-2.83%+90.82%+137.44% 89.1B
-4.09%-4.79%+41.40%+127.04% 62.33B
Average -4.29%-3.62%+55.28%+91.81% 162.34B
Weighted average by Cap. -3.63%-1.45%+57.23%+85.67%

Financials

2024 2025
Net sales 1.3B 194M 175M 161M 146M 273M 18.47B 276M 1.93B 767M 9.68B 730M 714M 30.7B 1.34B 200M 180M 166M 150M 281M 19.02B 285M 1.99B 790M 9.97B 751M 735M 31.61B
Net income 146M 21.96M 19.71M 18.2M 16.5M 30.84M 2.09B 31.22M 218M 86.64M 1.09B 82.42M 80.65M 3.47B 151M 22.64M 20.32M 18.76M 17.01M 31.8M 2.15B 32.19M 225M 89.33M 1.13B 84.98M 83.16M 3.57B
Net Debt 234M 35.1M 31.5M 29.08M 26.37M 49.29M 3.33B 49.9M 349M 138M 1.75B 132M 129M 5.54B 151M 22.61M 20.3M 18.74M 16.99M 31.76M 2.15B 32.15M 225M 89.23M 1.13B 84.89M 83.07M 3.57B
Projected Income Statement - Annual - Nanjing Well Pharmaceutical Group Co.,Ltd.
Logo Nanjing Well Pharmaceutical Group Co.,Ltd.
Nanjing Well Pharmaceutical Group Co Ltd is a China-based company primarily engaged in the research, development, production, and sales of pharmaceutical excipients and synthetic lubricating base oils. The Company's products mainly include mechanical synthetic lubricating base oils, non-mechanical synthetic lubricating base oils, injectable pharmaceutical excipients, and non-injectable pharmaceutical excipients. The Company distributes its products within the domestic market and to overseas markets.
Employees
718
Date Price Change Volume
27/10/26 CN¥26.01 -3.09% 1,340,760
26/10/26 CN¥26.84 +0.60% 1,466,100
23/10/26 CN¥26.68 +1.56% 3,096,400
22/10/26 CN¥26.27 -6.18% 4,758,070
21/10/26 CN¥28.00 +4.28% 5,795,560
  1. Stock Market
  2. Stocks
  3. 603351 Stock